Article
A blood‐based biomarker panel for stratifying current risk for colorectal cancer
30 Sept 2009
Abstract excerpt
Colorectal cancer (CRC) is often curable and preventable using current screening modalities. Unfortunately, screening compliance remains low, partly due to patient dissatisfaction with faecal/endoscopic testing. Recent guidelines advise CRC screening should begin with risk stratification. A blood-based test providing clinically actionable CRC risk information would likely improve screening compliance and enhance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
